Exelixis Shares Move 12% On Phase 3 Data
July 14, 2014 at 09:05 AM EDT
Shares of Exelixis (NASDAQ: EXEL) are rallying after the company announced positive phase 3 data for coBRIM. The study met its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.